Biofilm dispersal and exacerbations of cystic fibrosis lung disease [1]

Pediatric Pulmonology

Volumn 41, Issue 12, 2006, Pages 1254-

  Reid, D W ^a   Kirov, S M ^a   Webb, J S ^a   Carroll, V ^a   Kjelleberg, S ^a   Champion, A ^a   Sanderson, K ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIOPHAGE; BACTERIUM ISOLATE; BIOFILM; CYSTIC FIBROSIS; CYTOLYSIS; DISEASE EXACERBATION; HUMAN; LETTER; LUNG FUNCTION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SPUTUM ANALYSIS; TREATMENT RESPONSE;

ADULT; BIOFILMS; CYSTIC FIBROSIS; DISEASE PROGRESSION; HUMANS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SPUTUM;

EID: 33845431989     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20420     Document Type: Letter

References (3)

1. VanDevanter DR, Van Dalfsen JM. How much do Pseudomonas biofilms contribute to symptoms of pulmonary exacerbation in cystic fibrosis? Pediatr Pulmonol 2005;39:504-506.
2. Purevdorj-Gage B, Costerton WJ, Stoodley P. Phenotypic differentiation and seeding dispersal in non-mucoid and mucoid Pseudomonas aeruginosa biofilms. Microbiology 2005;151:1569-1576.
3. Kirov SM, Webb JS, Kjelleberg S. Clinical significance of seeding dispersal in biofilms. Microbiology 2005;151:3452-3453; discussion 3453.